Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RLI | ERAS |
|---|---|---|
| Price | $56.08 | $14.72 |
| Change today | ▲ 0.25% | ▼ 0.14% |
| Market cap | $5.15B | $5.15B |
| Return, 3 months | -9.5% | -19.8% |
| Return, year to date | -8.0% | +295.7% |
| Return, 1 year | -5.0% | +531.8% |
| P/E (TTM) | 11.8 | -15.5 |
| P/B | 2.9 | 14.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.18% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 33 | 42 |
| 30-day volatility | 19.5% | 58.4% |
| Max drawdown, 1 year | -27.9% | -59.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
